Trending

23andMe

France’s Doctolib is new digital health unicorn

France’s Doctolib is new digital health unicorn

Doctolib, the largest digital health service in Europe, has raised 150 million euros in a funding round, valuing

X

France’s Doctolib is new digital health unicorn

https://pharmaphorum.com/news/frances-doctolib-is-new-digital-health-unicorn/

FDA approves consumer colorectal cancer test

FDA approves consumer colorectal cancer test

The FDA will allow consumer DNA testing company 23andMe to give customers reports on their risk of hereditary

X

FDA approves consumer colorectal cancer test

https://pharmaphorum.com/news/fda-approves-consumer-colorectal-cancer-test/

FDA approval for 23andMe’s direct-to-consumer genetics test

FDA approval for 23andMe’s direct-to-consumer genetics test

Service can now be marketed as test for Alheimer’s and Parkinson’s, among others.

X

FDA approval for 23andMe’s direct-to-consumer genetics test

https://pharmaphorum.com/news/fda-approval-23andmes-direct-consumer-genetics-test/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com